These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10606894)

  • 21. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis.
    Otsuki T; Ichihara K; Tomokuni A; Sakaguchi H; Aikoh T; Matsuki T; Isozaki Y; Hyodoh F; Kusaka M; Kita S; Ueki A
    Int J Mol Med; 1999 Oct; 4(4):407-11. PubMed ID: 10493983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines.
    Dirks W; Schöne S; Uphoff C; Quentmeier H; Pradella S; Drexler HG
    Br J Haematol; 1997 Mar; 96(3):584-93. PubMed ID: 9054667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura.
    Yoshimura C; Nomura S; Nagahama M; Ozaki Y; Kagawa H; Fukuhara S
    Eur J Haematol; 2000 Apr; 64(4):219-24. PubMed ID: 10776692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum elevations of soluble Fas (CD95/apo-I) concur in deregulating T cell apoptosis during active lupus disease.
    Silvestris F; Williams RC; Calvani N; Grinello D; Tucci M; Cafforio P; Dammacco F
    Clin Exp Med; 2002 May; 2(1):13-27. PubMed ID: 12049185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. U2AF - Hypoxia-induced fas alternative splicing regulator.
    Vilys L; Peciuliene I; Jakubauskiene E; Zinkeviciute R; Makino Y; Kanopka A
    Exp Cell Res; 2021 Feb; 399(1):112444. PubMed ID: 33347855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
    Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
    McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
    Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
    Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
    Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
    Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas gene mutation in the progression of adult T cell leukemia.
    Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
    J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
    Wood CM; Goodman PA; Vassilev AO; Uckun FM
    Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble Fas/Apo-1 splicing variants and apoptosis.
    Cascino I; Papoff G; Eramo A; Ruberti G
    Front Biosci; 1996 Jan; 1():d12-8. PubMed ID: 9159204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hepatocytes produce an isoform of FAS that inhibits apoptosis.
    Krams SM; Fox CK; Beatty PR; Cao S; Villanueva JC; Esquivel CO; Martinez OM
    Transplantation; 1998 Mar; 65(5):713-21. PubMed ID: 9521208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.
    Jodo S; Kobayashi S; Nakajima Y; Matsunaga T; Nakayama N; Ogura N; Kayagaki N; Okumura K; Koike T
    Clin Exp Immunol; 1998 May; 112(2):166-71. PubMed ID: 9649177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.
    Micheau O; Solary E; Hammann A; Martin F; Dimanche-Boitrel MT
    J Natl Cancer Inst; 1997 Jun; 89(11):783-9. PubMed ID: 9182976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours.
    Tomokuni A; Aikoh T; Matsuki T; Isozaki Y; Otsuki T; Kita S; Ueki H; Kusaka M; Kishimoto T; Ueki A
    Clin Exp Immunol; 1997 Nov; 110(2):303-9. PubMed ID: 9367417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update.
    Wang M; Su P
    Syst Biol Reprod Med; 2018 Apr; 64(2):93-102. PubMed ID: 29299971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
    Shimaoka Y; Hidaka Y; Okumura M; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.